Question 1

What is Zimmer Biomet Holdings's P/E ratio?

Accepted Answer

Zimmer Biomet Holdings (ZBH) P/E ratio is 22.8× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month earnings (net income), using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/E ratio calculated?

Accepted Answer

P/E = Share Price ÷ Trailing Twelve-Month (TTM) Diluted EPS, or equivalently Market Capitalisation ÷ TTM Net Income. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/E ratio?

Accepted Answer

The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.

Question 4

What is a good P/E ratio for Zimmer Biomet Holdings?

Accepted Answer

There is no universal "good" P/E. As a rule of thumb, the S&P 500 has historically averaged a P/E in the mid-to-high teens; mature, slow-growth businesses commonly trade in the 10–18× range, while high-growth or asset-light companies often trade at 25–50×+. What matters is the comparison to sector peers and to the company's own historical range. For Zimmer Biomet Holdings specifically, the relevant sector benchmark is the current sector median of 24.2×.

Question 5

Is Zimmer Biomet Holdings's P/E ratio high or low?

Accepted Answer

Zimmer Biomet Holdings's P/E ratio of 22.8× is below its own 5-year average of 47.8× and below the sector median of 24.2×. That places the current reading at the 24th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Zimmer Biomet Holdings's historical P/E ratio range?

Accepted Answer

In the available daily series, Zimmer Biomet Holdings (ZBH) P/E ratio has ranged from a low of 9.7× in 2009 to a high of 651.8× in 2020. The 5-year average is 47.8× and the 5-year median is 31.6×.

Question 7

What was Zimmer Biomet Holdings's P/E ratio in 2025?

Accepted Answer

Zimmer Biomet Holdings (ZBH) P/E ratio at the end of 2025 was 25.1×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month earnings figure available at that date.

Question 8

Why does Zimmer Biomet Holdings's P/E ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (earnings). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$17.7B	$705M	25.1×	+1.9×	Dec 31, 2025
2024	$21B	$904M	23.3×	-1.4×	Dec 31, 2024
2023	$25.3B	$1.02B	24.7×	-90.9×	Dec 31, 2023
2022	$26.7B	$231M	115.6×	+51.5×	Dec 31, 2022
2021	$25.7B	$402M	64.1×	—	Dec 31, 2021
2020	$31B	-$139M	—	—	Dec 31, 2020
2019	$29.9B	$1.13B	26.4×	—	Dec 31, 2019
2018	$20.6B	-$379M	—	—	Dec 31, 2018
2017	$23.7B	$1.81B	13.1×	-52.5×	Dec 31, 2017
2016	$20.1B	$306M	65.6×	-69.9×	Dec 31, 2016
2015	$19.9B	$147M	135.5×	+109.8×	Dec 31, 2015
2014	$18.7B	$728M	25.7×	+5.4×	Dec 31, 2014
2013	$15.4B	$761M	20.3×	+5.8×	Dec 31, 2013
2012	$10.9B	$755M	14.5×	+2.4×	Dec 31, 2012
2011	$9.19B	$761M	12.1×	-4.7×	Dec 31, 2011
2010	$10B	$597M	16.8×	+0.6×	Dec 31, 2010
2009	$11.6B	$717M	16.2×	+6.0×	Dec 31, 2009
2008	$8.69B	$849M	10.2×	-9.1×	Dec 31, 2008
2007	$14.9B	$773M	19.3×	-2.3×	Dec 31, 2007
2006	$18B	$835M	21.6×	-0.5×	Dec 31, 2006
2005	$16.2B	$733M	22.1×	-13.2×	Dec 31, 2005
2004	$19.1B	$542M	35.3×	-12.6×	Dec 31, 2004
2003	$16.6B	$346M	47.9×	+17.3×	Dec 31, 2003
2002	$7.88B	$258M	30.6×	—	Dec 31, 2002


Medtronic (MDT)	22.2×
McKesson (MCK)	22.2×
Illumina (ILMN)	21.7×
ResMed (RMD)	21.6×
GE HealthCare (GEHC)	21.6×
Pfizer (PFE)	21.1×
Quest Diagnostics (DGX)	21.1×
Henry Schein (HSIC)	21.0×
AptarGroup (ATR)	20.9×
IQVIA (IQV)	20.7×
Biogen (BIIB)	19.7×
Zoetis (ZTS)	18.9×
Gilead Sciences (GILD)	18.8×
Humana (HUM)	18.5×
Regeneron Pharmaceuticals (REGN)	18.2×
Bristol-Myers Squibb (BMY)	17.0×
Elevance Health (ELV)	17.0×
HCA Healthcare (HCA)	15.8×
AstraZeneca (AZN)	14.7×
DaVita (DVA)	13.3×
Incyte (INCY)	13.1×
Cigna (CI)	11.1×
Novo Nordisk (NVO)	8.6×
Solventum (SOLV)	7.9×
Universal Health Services (UHS)	7.2×

P/E Ratio for Zimmer Biomet Holdings (ZBH) 2002-2026

P/E Ratio daily chart for Zimmer Biomet Holdings (ZBH)

Historical P/E Ratio for Zimmer Biomet Holdings (ZBH) from 2002 to 2025

About P/E Ratio at Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings P/E Ratio by Year

Zimmer Biomet Holdings P/E Ratio 2025: 25.1×

Zimmer Biomet Holdings P/E Ratio 2024: 23.3×

Zimmer Biomet Holdings P/E Ratio 2023: 24.7×

Zimmer Biomet Holdings P/E Ratio 2022: 115.6×

Zimmer Biomet Holdings P/E Ratio 2021: 64.1×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

Zimmer Biomet Holdings (ZBH) Key Financials